Chronic Liver Disease Progression (LiSyM-DP - Pillar II) (RWTH Aachen University Hospital - Experimental Molecular Imaging (ExMI)) ; LiSyM network (RWTH Aachen University Hospital - Experimental Molecular Imaging (ExMI)) ; LiSyM-Krebs Partnering (RWTH Aachen University Hospital - Experimental Molecular Imaging (ExMI))
This generic project is intended to be a forum for all LiSyM partner and external stakeholders interested in participating in the BMBF initiative LiSyM-Krebs.
Organisms: Not specified
Chronic liver diseases (CLD) progression leads to cirrhosis, often cancer, and ultimately to organ failure and death. Because of the complexity of this scenario, a Systems Medicine approach is chosen to develop strategies to better characterize progression and resolution of fibrosis. Pillar II aims to define key molecular mechanisms and structural changes in tissue architecture during the progression of CLD by visualizing and quantifying at a cellular level, tissue and organ scale.
Date Published: 8th Aug 2019
Journal: Mol Imaging Biol
PubMed ID: 31396770
Citation: Mol Imaging Biol. 2019 Aug 8. pii: 10.1007/s11307-019-01417-3. doi: 10.1007/s11307-019-01417-3.
Authors: Tatjana Repenko, Anne Rix, Simon Ludwanowski, Dennis Go, Fabian Kiessling, Wiltrud Lederle, Alexander J. C. Kuehne
Date Published: 1st Dec 2017
Journal: Nat Commun
Citation: Nat Commun 8(1) : 2